Structural Formula (Doxepin HCl Cream 5 Percent 1)
Doxepin Hydrochloride Cream
Product Images NDC 69238-1733
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxepin Hydrochloride (NDC 69238-1733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tube (Doxepin HCl Cream 5 Percent 2)
Product: Doxepin Hydrochloride Cream, 5%
NDC: 69238-1733-6
Net Weight: 45g
This cream is intended for topical dermatologic use only. It contains Doxepin Hydrochloride with a 5% concentration.
Warnings: This cream should not be used orally, intravaginally, or in the eyes. Keep it away from eyes and out of reach of children.
Directions: Apply a thin film of Doxepin Hydrochloride Cream, 5% four times a day, with at least a 4-hour interval between applications. Reduce the surface area treated, the number of applications per day, or the amount of cream applied if excessive drowsiness occurs. Discontinue use if necessary.
Refer to the product insert for prescribing information and a list of inactive ingredients. Store the cream at or below 27°C (80°F).
Please check the crimp for the lot number and expiration date.
Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.
Revision date: 02-2022-01.*
Carton (Doxepin HCl Cream 5 Percent 3)
This text appears to be a description and instructions for the use of a medication called "Doxepin Hydrochloride Cream, 5%". The cream is intended for external use only and should not be taken orally, intravaginally, or used in the eyes. It should be kept out of reach of children. The directions state to apply a thin film of the cream four times a day, with at least a 3-4 hour interval between applications. If excessive drowsiness occurs, adjustments such as reducing the area of application, number of applications, or amount of cream applied may be necessary. The text also mentions the inactive ingredients of the cream and provides the storage temperature. The product is distributed by Bidgenar and has a National Drug Code (NDC) of 69238-1733-6.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
